| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
1996-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2000-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2000503986-A |
| titleOfInvention |
Use of delavirdine and protease inhibitors in HIV-1-positive humans |
| abstract |
(57) Abstract: A human infected with the HIV-1 virus is treated with an HIV-1 effective amount of delavirdine of the formula (I) or a pharmaceutically acceptable salt thereof and one or more HIV-1 effective amounts. Disclosed is a method of treating a human infected with the HIV-1 virus in need of such treatment, comprising administering a protease inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014530180-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140075711-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008531636-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101983416-B1 |
| priorityDate |
1996-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |